- Two industry leaders are joining forces to empower people with diabetes by providing information and insights to improve weight loss, glucose control and overall health.
- The collaboration will create a seamless, integrated experience for Abbott’s world-leading continuous glucose monitoring device.1 and WeightWatchers, the first doctor-recommended weight loss program2 to help individuals better understand and manage their diabetes and weight
ABBOT PARKUnhealthy., in 2022 August 4 /PRNewswire/ — Abbott (NYSE: ABT ) and WW International, Inc . (WeightWatchers or WW) today announced a strategic partnership to help people with diabetes better understand and manage their diabetes and weight. The companies are working together to integrate WeightWatchers’ diabetes-friendly weight management program with Abbott’s FreeStyle Libre portfolio.® products to create a seamless mobile experience that will give people with diabetes the information and insights they need to make healthy dietary adjustments, improve glucose levels and ultimately take better control of their health.
Maintaining a healthy body weight and eating well are essential to living well with diabetes.3 But for many people with diabetes, the hardest part of managing diabetes is figuring out what to eat and sticking to a meal plan.4 Through this partnership, participants can gain glucose insights from Abbott’s FreeStyle Libre sensor-based technology, which shows the impact of food choices and empirically validated data.5 WeightWatchers diabetes-specific nutrition guidelines to help them reach their goals for a healthier life.
“We strive to put our customers at the heart of everything we do, and that includes forming strategic partnerships with key industry leaders like WeightWatchers to deliver new services and offerings that can significantly improve the quality of life for people with diabetes.” said Jared Watkin, senior vice president of Abbott’s diabetes care business. “Combining our leadership in the world1 FreeStyle Libre Glucose Monitoring Technology with WeightWatchers, the first doctor-recommended weight loss program,2 People with diabetes, especially those with type 2 diabetes who are less intensively treated by their doctors, may have the insights they need to take control of their health.
The two companies will work together to share information between Abbott’s FreeStyle Libre continuous glucose monitoring system and the WeightWatchers mobile app so that people with diabetes can view their glucose data with the WeightWatchers diabetes app.
“Lifestyle changes, including changes in diet and activity habits, have been shown to be an essential component of diabetes management and can help improve glycemic control.”6said Sima Sistani, executive director of WeightWatchers. “We’re partnering with Abbott, a leader in diabetes care, to help people with diabetes reach their weight and healthy lifestyle goals while enjoying the foods they love and better managing their glucose levels.”
The partnership will initially focus on solutions for people with diabetes United States in 2023.
Abbott is a global leader in healthcare, helping people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare with leading businesses and products in diagnostics, medical devices, nutrition and branded generics. Our 113,000 colleagues serve people in more than 160 countries.
Connect with Abbott at www.abbott.com, LinkedIn at www.linkedin.com/company/abbott-, Facebook at www.facebook.com/Abbott and Twitter @AbbottNews.
About WW International, Inc.
WeightWatchers is a human-centered technology company that leads the world’s leading commercial weight management program. For nearly six decades, we’ve inspired millions of people to adopt healthy habits in real life. With our comprehensive tools, expert coaches and community, members follow our proven, sustainable, science-based program focused on weight loss. To learn more about the WeightWatchers approach to healthy living, visit www.com. For more information about our global business, please visit our corporate website at corporate.ww.com.
Indications and important safety information
FreeStyle Libre 14 Day System: Failure to use the FreeStyle Libre 14-Day System as directed on the label may result in a missed high or high blood glucose event and/or treatment decision and injury. If readings do not match symptoms or expectations, use the finger stick reading to guide treatment decisions. Get medical attention if needed or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety information.
FreeStyle Libre 2 and FreeStyle Libre 3 systems: If you do not use the FreeStyle Libre 2 or FreeStyle Libre 3 systems as directed on the label, you may miss a high or high blood glucose event and/or make a treatment decision that could lead to injury. If glucose alerts and readings do not match symptoms or expectations, use the finger stick reading from your blood glucose meter to guide treatment decisions. Get medical attention if needed or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety information.
1Data on file, Abbott Diabetes Care. Data based on the number of users of the FreeStyle Libre portfolio worldwide compared to the number of users of other personal use sensor-based glucose monitoring systems.
2 Based on the 2020 IQVIA survey of 14,000 physicians who recommend weight loss programs to patients.
3 Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, Mitri J, Pereira RF, Rawlings K, Robinson S, Saslow L, Uelmen S, Urbanski PB, Yancy WS Jr. Nutrition therapy in adults with diabetes mellitus or prediabetes: a consensus report. Diabetes care. in 2019 May;42(5):731-754. doi: 10.2337/dci19-0014. Epub, 2019 April 18 PMID: 31000505; PMCID: PMC7011201.
4 American Diabetes Association. “5. Facilitating Behavioral Change and Wellness to Improve Health Outcomes: Standards of Medical Care for Diabetes – 2021”. Diabetes Care 44, no. Supplement 1 (2021): S53-S72.
5 Apolzan JW, LaRose JG, Anton SD, et al. A weight management program tailored to adults with type 2 diabetes: effects on glycemic control. Poster presented at: American Diabetes Association 82nd Scientific Sessions; in 2022 June 5-6; New Orleans, LA.
6 American Diabetes Association. Lifestyle Management: Standards of Medical Care for Diabetes – 2019 Diabetes care. 2019;42(1):S46–S60. https://doi.org/10.2337/dc19-S005